The Food and Drug Administration’s vaccine advisory committee voted overwhelmingly against recommending the approval of a booster shot of Pfizer-BioTech’s coronavirus vaccine for people 16 and older on Friday, dealing a significant blow to the federal government’s plan for mass distribution of a third shot.
